+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan



Cocirculation of antigenic variants and the vaccine-type virus during the 2004-2005 influenza B virus epidemics in Japan



Journal of Clinical Microbiology 47(2): 352-357



In the 2004-2005 season, there was a large epidemic of the influenza B virus Yamagata group in Kobe, Japan. In hemagglutination inhibition tests, most of the clinical isolates from Kobe showed antigenicities similar to those of previous isolates (the vaccine-type virus). Only a few antigenic variants were isolated around the peak of the epidemic; however, Kobe residents developed antibodies against the variants during the season. The antigenic variants showed a one-point mutation of a nucleotide in the HA1 gene (C440A or G421A), which resulted in the substitution of one amino acid in the 150 loop of the HA molecule (T147N or G141R). The 150 loop is one of four epitopes of the hemagglutinin molecule of the influenza B virus. We established a system to detect one-point differences in the nucleotides of the 150 loop by means of high-resolution melting curve analysis with LCGreen. With this system, the isolates were determined to be the vaccine-type virus, antigenic variants, or a mixture of both. Some isolates were shown to be mixtures although they had been recognized as the vaccine-type virus with the hemagglutination inhibition tests. Thus, the antigenic variants appeared in the early period of the epidemic and were cocirculating with the vaccine-type virus during the epidemic.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 052154187

Download citation: RISBibTeXText

PMID: 19091818

DOI: 10.1128/jcm.01357-08


Related references

Studies on survival of influenza virus between epidemics and antigenic variants of the virus. American Journal of Public Health and the Nation's Health 39(2): 171-178, 1949

Supplement: Sixth International Symposium on Avian Influenza || Evolutionary Analysis of HA and NS1 Genes of H5N1 Influenza Viruses in 2004-2005 Epidemics (Anlisis de la evolucin de los genes HA y NS1 de los virus H5N1 en las epidemias de los aos 2004-2005). Avian Diseases 51(1): 455-460, 2007

Seasonal patterns of respiratory syncytial virus, influenza A virus, human metapneumovirus, and parainfluenza virus type 3 infections on the basis of virus isolation data between 2004 and 2011 in Yamagata, Japan. Japanese Journal of Infectious Diseases 66(2): 140-145, 2013

Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004. Vaccine 25(1): 154-160, 2006

Supplement: Sixth International Symposium on Avian Influenza || Geographic and Temporal Distribution of Highly Pathogenic Avian Influenza A Virus (H5N1) in Thailand, 2004-2005: An Overview (Revisin de la distribucin geogrfica y temporal del virus A de influenza aviar de alta patogenicidad H5N1 en Tailandia, 2004-2005). Avian Diseases 51(1): 182-188, 2007

Antigenic and genetic study of influenza virus B circulated in China in 2004-2005. Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 20(2): 11-13, 2006

Predicting antigenic variants of H1N1 influenza virus based on epidemics and pandemics using a stacking model. Plos one 13(12): E0207777, 2018

Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine-mediated immune protection. Immunology 148(2): 160-173, 2016

Antigenic and genetic study of influenza virus (H1N1) circulated in China in 2004-2005. Zhonghua Shi Yan He Lin Chuang Bing du Xue Za Zhi 20(2): 27-29, 2006

Antigenic variants of influenza A virus IV Serological characteristics of a second line of variants developed in mice given polyvalent vaccine. Jour Exptl Med: 845-855, 1958

Antigenic variants of influenza A virus ID Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. Jour Exptl Med: 829-844, 1958

Antigenic variants of influenza A virus (PR8 strain). IV. Serological characteristics of a second line of variants developed in mice given polyvalent vaccine. Journal of Experimental Medicine 107(6): 845-855, 1958

Antigenic variants of influenza A virus (PR8 strain) III. Serological relationships of a line of variants derived in sequence in mice given homologous vaccine. Journal of Experimental Medicine 107(6): 829-844, 1958

Emerging antigenic variants at the antigenic site Sb in pandemic A(H1N1)2009 influenza virus in Japan detected by a human monoclonal antibody. Plos one 8(10): E77892, 2013

The antigenic structure of neuraminidases of influenza type a virus vaccine strains used in the production of live oral influenza vaccine. Voprosy Virusologii (3): 287-289, 1976